Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO).
Henna K SöderströmJari RäsänenJuha SaarnioVesa ToikkanenTuula TyrväinenTuomo RantanenAntti ValtolaPasi OhtonenMinna PääahoArto KokkolaRaija KallioTuomo J KarttunenVesa-Matti PohjanenAri RistimäkiSimo LaineEero SihvoJoonas H KauppilaPublished in: BMJ open (2020)
Even though Finland only has a population of 5.5 million, surgery for oesophageal carcinoma has not been centralised and therefore previously reported results have mostly been small, single-centre cohorts. Because of FINEGO, we now have a population-based, unselected cohort of surgically treated patients, enabling research on national trends over time regarding oesophageal cancer, including patient characteristics, tumour histology, stage and neoadjuvant treatment, surgical techniques, hospital volumes and patient mortality. Data collection is ongoing, and the cohort will be expanded to include more detailed data from patient records and national biobanks.
Keyphrases
- case report
- papillary thyroid
- quality improvement
- newly diagnosed
- end stage renal disease
- electronic health record
- squamous cell
- minimally invasive
- rectal cancer
- chronic kidney disease
- emergency department
- lymph node
- squamous cell carcinoma
- machine learning
- coronary artery disease
- cross sectional
- coronary artery bypass
- radiation therapy
- cardiovascular disease
- type diabetes
- risk factors
- childhood cancer
- prognostic factors
- atrial fibrillation
- combination therapy
- lymph node metastasis
- deep learning
- percutaneous coronary intervention
- surgical site infection